PolyPeptide Group AG reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 131.83 million compared to EUR 133.66 million a year ago. Revenue was EUR 133.38 million compared to EUR 134.61 million a year ago.

Net loss was EUR 34.27 million compared to net income of EUR 10.25 million a year ago. Basic loss per share from continuing operations was EUR 1.04 compared to basic earnings per share from continuing operations of EUR 0.31 a year ago. Diluted loss per share from continuing operations was EUR 1.04 compared to diluted earnings per share from continuing operations of EUR 0.31 a year ago.